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INTRODUCTION: 
    Pancreatic pseudocysts are encapsulated collections of necrotic tissue, 
old blood and secretions walled off by granulation tissue from the 
pancreas. The prefix “pseudo” is used to emphasize the fact that these 
collections frequently have no true capsule and that the cyst wall is made 
up of adjacent viscera such as the stomach and / or colon. 
The pseudocysts are the most common complications following pancreatic 
inflammation both acute and chronic. They also constitute the most 
frequently encountered cystic lesions of the pancreas others being the 
cystic neoplasms. For the pseudocysts<5cms there are chances of 
autoregression. 
The pseudocysts present clinically as epigastric pain, abdominal 
masses to jaundice. The laboratory findings are not much of use in the 
diagnosis of these pseudocysts. It is radiology which helps in the diagnosis 
of the pseudocysts with the help of USG, CT scan, MRI, etc. These 
investigations govern the therapeutic procedures to be carried out. 
Essentially the treatment for pseudocyst is multimodal one. The treatment 
team for pseudocysts includes radiologists, endotherapists and surgeons. 
The radiologists by way of guided per-cutaneous techniques for 
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aspiration/drainage to the therapeutic embolization of bleeding 
aneurysms and the endotherapists by way of various endoscopic drainage 
procedures contribute to the team. The various diagnostic and therapeutic 
procedures available for intervention are also studied and effectiveness of 
USG guided aspiration as the primary modality of treatment as compared 
to conventional surgeries is also studied. 
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Aims and Objectives 
 
1. To compare USG guided per-cutaneous aspiration with 
the surgical treatment options available for pseudocyst of 
pancreas in terms of patient and physician factors. 
2. To compare the various surgical drainage procedures 
that has been employed for the treatment of pseudocysts 
of pancreas. 
3. To compare the results of endoscopic drainage vs 
surgical procedures employed for drainage of pancreatic 
pseudocysts. 
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Review Of Literature 
EMBRYOLOGY OF PANCREAS: 
        Two pancreatic primordial – ventral and dorsal forms the pancreas. 
Dorsal primordium develops on 26
th
 day and ventral primordium develops 
on 32
nd
 day both fuse on 37
th
 day. Ventral pancreas forms duct of 
wirsung,part of uncinate process and head of pancreas. Dorsal pancreas 
forms remainder of the uncinate process and head ,also body and tail of 
pancreas. 
SURGICAL ANATOMY :  
The precise anatomy of the pancreas, its ducts, and its adjacent blood 
vessels achieves great importance in operating on the pancreas. Failure to 
be wary of the implications of surgical procedures on the pancreas is often 
followed by a string of complications that are serious at best and are not 
unlikely to be fatal. In this regard, the pancreas is one of the most 
treacherous organs to operate on. 
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PARTS OF PANCREAS: 
 
 
 
Five parts of pancreas. Line dividing body and tail is entirely arbitrary.  
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ANTERIOR RELATIONS OF PANCREAS: 
 
 
 
 
 
POSTERIOR RELATIONS OF PANCREAS: 
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Ductal System of the Pancreas 
20 to 200 acinar cells present within each pancreatic lobule  drain 
into  small intercalated ducts  these merge to form intralobular ducts  
which further merge to form secondary pancreatic ducts that drain  
into the main pancreatic duct (MPD or duct of Wirsung) 
MPD gradually increases in caliber from approximately 1 to 2 mm in 
the tail, 2 to 3 mm in the body, and 3 to 4 mm in the head.  The 
uncinate process has its own pancreatic duct, usually drains into the 
MPD as it becomes more horizontal, just before the major duodenal 
papilla.  
The accessory pancreatic duct (of Santorini) is the proximal portion 
of the duct draining the dorsal pancreas. With fusion of the ducts 
from the dorsal and ventral pancreas, the accessory duct assumes a 
secondary role and tends only to drain the anterosuperior portion of 
the pancreatic head. However, sometimes when the ducts do not 
fuse (≈ 10%), called pancreas divisum, the accessory duct drains the 
entire dorsal pancreas and none of the uncinate process. The minor 
duodenal papilla, located approximately 1 to 2 cm proximal and 
anterior to the major duodenal papilla.  
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The major duodenal papilla is located on the posteromedial wall of 
the duodenum, in the second part, 7 to 10 cm distal to the pylorus.  
The anatomy of the sphincter complex at the major duodenal papilla, 
(Boyden and Oddi,) is also variable. There are several sphincters of 
smooth muscle within the complex. 
 The length of the sphincter complex may vary from 6 to 30 mm, 
which probably explains why it is sometimes difficult to achieve a 
complete endoscopic sphincterotomy. The sphincter complex 
comprises four elements: a superior biliary sphincter, an inferior 
biliary sphincter (submucosal), a common ampullary sphincter, and a 
pancreatic sphincter  
Nerve Supply of the Pancreas 
Innervation of the pancreas occurs by the  
1.splanchnic nerves (sympathetic) and  
2. the vagus nerve (parasympathetic).  
Both contain efferent vasomotor supply  to the pancreatic acini, 
ducts, and blood vessels – controls exocrine and endocrine 
functions 
17 
 
 
Afferent pain fibers   is  important  as pain is a feature of both benign 
and malignant pancreatic diseases.  
Factors governing pain include perineural infiltration by cancer, 
damage to perineurium, inflammatory mediators, ductal 
hypertension, and compartment syndrome. Pancreatic pain is poorly 
localized.  
Pain is most often referred to the epigastrium and to the midback. 
The interruption of pain is an important therapeutic goal  - includes 
various modalities surgical, thoracoscopic, radiologic, and 
endoscopic chemical approaches. The mainstay of analgesia 
remains pharmacology. 
The preganglionic sympathetic nerves are from the greater (T5-T10), 
the lesser (T9-T11), and sometimes the least splanchnic nerves. 
Postganglionic nerve fibers reach the pancreas by accompanying 
branches of these arteries as periarterial plexi. 
The preganglionic parasympathetic nerves, from the celiac division 
of the posterior vagal trunk, synapse with ganglia within the 
pancreas. The postganglionic fibers terminate at the pancreatic islet 
cells. Innervation of the islets cells is almost exclusively from the 
parasympathetic side, and fibers frequently synapse with acinar cells 
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before reaching the islet cells, suggesting neural coordination 
between exocrine and endocrine components.  
Arising in the pancreas, the afferent (visceral) pain fibers pass 
cranially through the celiac plexus to their cell bodies in the dorsal 
root ganglia within the splanchnic nerves, crossing to the spinal 
nerves by way of the white communicating rami and at a spinal level 
comparable to the preganglionic sympathetic fibers. 
Physiology of  Exocrine Pancreas 
The functional unit of the exocrine pancreas is the acini , the 
collection of acinar cells responsible for the secretion of digestive 
enzymes, pancreatic fluid, and electrolytes via the ductal network. 
Digestive enzymes are synthesized in the acini& stored  in zymogen 
granules, released at the cell apex by exocytosis into the ducts. 
Significant defenses exist to prevent premature intra-acinar enzyme 
activation (a key feature of acute pancreatitis). These  include 
compartmentalization in the granules, separation from lysozymes, 
trypsin inhibitors, and antiproteases. Enteropeptidase  in the 
intestinal wall activates trypsinogen to trypsin which in turn activates 
a cascade of the other digestive enzymes. 
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The exocrine pancreas secretes 800 mL/day or more of alkaline 
fluid, with a high HCO3
– content . 
Exocrine function of the pancreas is controlled via the hormones 
gastrin, cholecystokinin (CCK), and secretin. Secretin stimulates 
cells to produce  alkaline pancreatic juice that has low levels of 
digestive enzymes. CCK  causes degranulation  of zymogen 
granules and production of secretion rich in enzymes but low in 
volume.  Stimulation of the vagi  releases  secretion of a small 
amount of pancreatic juice rich in enzymes.  
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Pseudocyst Of Pancreas  
 
Introduction 
Pseudocysts are the most common cystic lesions of the pancreas.Other cystic 
lesions including cystic neoplasms represent only 15% of pancreatic cysts . 
Wider use of ultrasound &CT in asymptomatic and mildly symptomatic patients 
has increased detection of incidental cystic lesions of the pancreas so that the 
differential diagnosis of pancreatic cystic lesions has become more challenging. 
Increase in knowledgeabout intraductal papillary mucinous tumor (IPMT) has 
resulted in better diagnosis & differentiation Differentiating pancreatic 
pseudocysts from nonpseudocysts is important for determining treatment. 
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Classification 
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Epidemiology 
 The incidence  of pseudocyst 
                                                 -  5 - 15% in acute pancreatitis 
                                                 -  20 - 40% in chronic pancreatitis 
 
The most common causes  for pancreatitis  include alcohol 
related(56-78%)  and gall stone/ biliary diseases.( 6-36%). Rarer 
causes include infective, post-surgical, traumatic & hyperlipidemia 
or other metabolic causes. 
Clinical Presentations:: 
1. Pain:  
Pain in pseudocyst generallly  dull aching in epigastrium, 
may  be referred to back. Sometimes pain may be 
secondary to distension of stomach following  obstuction & 
compression by the cyst directly 
2. Bleeding: 
Variceal bleed UGI bleed with/without malena secondary to 
portal gastropathy due to splenic vein 
involvement(thrombosis/compressionn). 
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Sometimes bleeding may occur into pseudocyst after major 
arterial erosion, or if abnormal communication into small 
bowel.  
3. Infection 
Infection of pancreatic pseudocysts arises from intestinal 
flora. May result in sepsis if communication into blood 
stream occurs. Generally gram negative or anaerobic 
organisms are the cause( coliforms, enterobacteria) 
4. Splenic vein thrombosis 
Occursin pseudocysts when located in the body/tail or in 
relation to chronic pancreatitis.  
5. Pancreatic biliary ductal obstruction 
Occurs secondary to distal CBD , Pancreatic duct 
obstruction either due to direct compression over the head 
of the pancreas or fibrotic changes near the ampulla. 
Presents as obstructive Jaundice.  
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Diagnostic Modalities  
The most important diagnostic elements  for pseudocyst of pancreas 
include ultasound abdomen, contrast CT abdomen, ERCP & MRCP. 
Other than this basic laboratory investigations, liver functions 
parameters, Serum amylase, lipase, tumor markers including CEA, 
CA 19-9 to rule out cystic neoplasms of pancreasms may be 
necessary. 
 
Howere the final diagnosis must correlate with the clinical condition 
of the patient . 
 
Ultasound: 
Ultasound abdomen  is a simple, cheap and non-invasive modality 
that must form the first line of  investigation for diagnosis of 
pancreatic pseudocysts.  
 
Pancreas can  be visualized in 80% of patients,  hence the technique 
is highly examiner dependent. 
 
Sensitivity of 88–100%  
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Specificity of 92–98% . 
But the negative predictive value (NPV) 9%, so not an ideal tool to 
exclude small pancreatic pseudocysts. In conjunction with a colour 
doppler probe(which facilitates better visualisation of blood vessels) 
it is an ideal tool for interventional treatment. 
Endoscopic ultrasound (EUS) 
This is a relatively recent diagnostic tool couples high resolution 
ultrasound probe to the tip of the  endoscope.  It detects most  of the 
cystic lesions of the pancreas andfor small lesions <2 cm in diameter, 
Endo Ultrasound has  higher diagnostic sensitivity .  
Endoscopic ultrasound is superior to CT for  smaller  lesions (less 
than 2 cm in size) because of its better spatial resolution.  
It detects debris within a pseudocyst with higher sensitivity . 
Useful for tissue sampling ( EUS guide FNA ) to rule  cystic 
malignancies. 
 
Computed Tomography  
A contrast Computed Tomography  scanning of the abdomen is 
compulsory for planning the therapy of a  pseudocyst. 
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Overall sensitivity (82–100%)  
Specificity 98%, 
NPV: 92–94% 
Overall accuracy of 88–94%. 
 
Pseudocysts mostly appear as round, fluid-filled cavities surrounded 
by a dense wall.  
 
CECT scan accurately shows the  location of the cyst and thickness of  
cyst wall, internal architecture of pseudocysts, presence of  necrotic 
and devitalised debris and proximity of pseudocysts to major 
vascular / vital structures.
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Endoscopic Retrograde CholangioPancreaticography (ERCP) 
ERCPplay s major role in the management of pseudocysts both as a 
diagnostic and therapeutic tool.  
Eventhough it provides less information regarding the size& 
surrounding structures than CT and  USG,  it  accurately delineates  
the pancreatio  biliary  anatomy. 
Further,  ERCP is essential modality without whose help many 
classification systems for pseudocysts would be difficult. Eg: Nealon 
and Walser  or D'Egidio and Schein classification systems. 
Sensitivity 40-69%(to identify communication of cysts with the  
duct). 
 
Role of ERCP 
 Duct  - pseudocyst communication - sensitivity 40-69% 
 Common bile duct stricture - Incidence3-23% 
 Decides interventions including transpapillary approach for 
drainage 
 Deciding the Surgical  management(for decision about the 
drainage  modality). 
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The complications of ERCP include retrograde introduction of 
infections, bleeding from major vessels, hollow viscus injury, stent 
displacement , migration. 
Magnetic Resonance CholangioPancreatography 
Sensitivity - 70% - 90% ( Gold standard -ERCP).  
MRCP has much lesser complications  than ERCP . 
It is less examiner-dependent when compared to abdominal 
ultrasound. 
These features has led to its increased use as a diagnostic modality 
for chronic pancreatitis,,  in spite of its  significantly higher cost and 
its inherent lack of therapeutic options.  
MRCP is inferior to ERCP  in the  diagnosis of cyst–duct 
communication. 
Communications between cyst and duct can  be identified by MRCP 
only if a high intensity fluid tract is present  between them. 
Further developments in MRI technology will definitely brighten the 
prospects  of MRCP for replacing more invasive diagnostic 
procedures. 
 
Pathogenesis of Acute Pseudocysts 
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Acute pancreatic pseudocyst formation is a complex process which starts 
as an inflammatory process, slowly matures with the collection of 
pancreatic debris/ products & residues of inflammation  with possible 
rupture of pancreatic duct into more of an organised cyst.. It may either be 
secondary to duct disruption(secondary to pancreatic necrosis) or mere 
peripancreatic collectionsfollowing oozing from inflamed pancreatic 
surface. 
Collections of pancreatic juice generally remain as local collections in the 
region of duct disruptions. If these collections break  the thin layer of 
mesenchymal connective tissue around the pancreas, it reaches  the 
anterior pararenal space or  the lesser sac. 
 The most common site for  accumulation of these pancreatic collections  
is the lesser sac, bounded between stomach, transverse mesocolon. 
Spleen and duodenum. 
 
At first, these fluid collections are ill defined, extending along the peri-
pancreatic and para-renal regions, and henceshould actually be called 
acute fluid collections in this phase. Most of these  follow an attack of 
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acutepancreatitis and will  resolve themselves if there is no secondary 
infection or large quantity of debris. 
If these acute fluid collections stays on for> 4-6 weeks without 
spontaneu=ous resolution they develop thick wall & can be termed as 
pseudocysts. However with time due to fibrosis the pancreatic duct- cyst 
fistula may spontaneously close. 
Pathogenesis of Chronic Pseudocysts 
For the pathogenesis of pseudocyst formation in chronic pancreatitis two 
mechanisms may be involved.  
1.Acute exacerbation of underlying disease process. This is the reason for 
cysts appearing in acute on chronic pancreatitis. 
2.Block / disruption of a major  pancreatic duct by a protein ,calculus/ 
fibrosis may lead to pancreatic cysts or pseudocyst  formation . 
Wheneverther is blockage to distally there is proximal saccular dilatation 
of the system. 
These lead to the formation of Retention cysts(True cysts). Intially 
multilple microcysts form  which may eventually coalesce to form bigger 
pseudocysts..  
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Pancreatic duct injury plays a major role in the pathogenesis of chronic 
pancreatic pseudocysts. The pancratic duct is most prone for damage at its 
angulation "genu" were it turns acutely. 
 
 
 
 
 
Anatomical Extensions of Pseudocyst 
Pseudocysts are generallly limited to the pancreas and the peri pancreatic 
spaces. But sometimes they extend into nearby potential spaces and 
compartments thereby causing significant symptoms according to their 
36 
 
 
target site.
 
 
 
Morphology of Pseudocyst 
The Pseudo cyst of pancreas lack a true cyst wall. It is merely the fibrotic 
condensation of inflammatory material around the cyst. There are no clear 
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lines of demarcation  between the well-developed pseudocyst and the 
adjacent normal anatomical structures. This fact has to be born in mind  
both for pathogenesis and treatment.On gross inspection of the 
pseudocyst wall, generally connection with the  pancreatic duct system 
cannot be identified although, by endoscopic pancreatography, 
connections can be demonstrated.  
The pseudocyst is generally fluctuant because of its  cystic contents. The 
contents may vary widely from a colourless  clear to turbid fluid to 
brownish thick fluid with pancreatic debris to frank purulent material . 
Rarely, the fluid can also be blood-tinged or frankly hemorrhagic.  
Pseudocysts are mostly  single, but rarely could be multiple(10%).  
Pancreatic pseudocysts are  commonly round to  oval, but some may be 
multilocular and irregular in shape. The size of pseudocysts varies from 2 
to as large as 35 cm.  
Estimated capacity ranges between 10ml and 6L. The serum amylase, 
lipase, and trypsin contents are generally markedly elevated.  
The amylase level may be lower in older pseudocysts, indicating the 
etiology to be chronic rather than acute pancreatic insult. The 
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spontaneous disappearance of small cysts may be due to the loss of 
connection with the pancreatic duct system.. 
 
 
 
 
 
 
 
 
 
 
TREATMENT 
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Previously very limited options were available for the 
management of pseudocysts. Surgery was the  only availabe 
option. The controversy was primarily regarding the time of 
intervention. 
Early intevention led to unnecessary increase in the rates of 
external drainage. . With improvements in technology and newer 
minimally interventional modalities image guided percutaneous 
drainage, endoscopic and laparoscopic drainage methods have 
become more popular. 
With increase in the choice of options available the decision to 
choose the apt method has become more complex. 
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a.  
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Surgery  has been  the mainstay of treatment for pancreatic 
pseudocysts for long. Itis being  challenged by the newer 
endoscopic & interventional techniques.  
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With the introduction of endoscopic ultrasonography, endoscopic 
drainage has become safer and the risks associated with 
endoscopic drainage have come down. Complete remission and 
disappearance of symptoms after surgical and endoscopic 
methods are near comparable, but decision to choose either 
method depends on the patient and logistic factors.  
PERCUTANEOUS CATHETER DRAINAGE 
Pseudocysts can be drained by USG or CT guidance. It could be 
either temporary by needle aspiration - in which it could be used 
as a therapeutic modality or for diagnostic purposes(to quantify 
enzymes, cancer markers).  Following drainage a pigtail catheter 
can be left in side the cyst cavity, so as it can act as a continuous 
drain. It is left in situ till no further drain is obtained.  
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INDICATIONS AND CONTRAINDICATIONS 
The indications for percutaneous drainage are same as those for 
surgery. 
These include- 
 Persistent pain, 
 Sepsis , 
 Involvement of nearby organs, 
 Increasing size, 
 Obstructive jaundice 
 GOO 
But its use is more important in the management of immature 
symptomatic fluid collections. It is of particular use in patients at 
high risk and morbid patients who may not withstand 
surgery/endoscopy, as a temporary palliation. 
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PERCUTANEOUS DRAINAGE- TIMING 
Timing of the procedure is not important for the percutaneous 
drainage, as it does not require the maturation of the wall as for 
surgery.. The only criterion required is image proof that the 
pseudocyst does need drainage. 
 
PERCUTANEOUS ASPIRATION-RESULTS 
Percutaneous aspiration is safe& ideal for diagnosis but is usually 
ineffective for therapy with a curatuve intent.  
Especially those chronic pseudocysts that have thick walls and are 
surroundedby fibrosis ,into which needle aspiration may not be 
effective in collapsing the walls. 
The pseudocysts with ductal communication, which may be in 50 
percent to 75 percent of cases, generally reaccumulate fluid 
usually within a day of aspiration. 
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According to some authors pseudocysts that do  not 
communicate with the pancreatic duct system can be drained with 
a fine-needle evacuation. It hasmany benefits including  
instantaneous pain relief and clinicalimprovement, but at the same 
time the risk of introducing external infections and fistula 
formation by indwelling catheter is reduced. 
But In the case where the pseudocyst content is purulent or when 
the cyst fluid is thick/difficult to evacuate completely, then an 
indwelling  catheter must be inserted. 
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ENDOSCOPIC DRAINAGE 
The therapeutic concept behind endoscopic drainage is that , the 
pseudocyst does not have its own structure, instead it is a space 
bounded by other abdominal organs. 
This makes the pseudocyst accessible from other accesible organs. 
Usually, the pseudocyst is accessed from stomach(transgastric) or 
through the common papilla(transpapillary).  
Endoscopic drainage of pancreatic pseudocyst appears to be a 
effective, safe and definitive procedure for patients whose 
anatomic considerations allow its use. 
This knowledge should be adequately understood and utilized 
appropriately by the surgical community . 
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INDICATIONS AND BASIC PRINCIPLES 
Endoscopic drainage methods are basically extensions of OGD 
scopy and ERCP techniques and rely on the use of the therapeutic 
duodenoscope/ERCP accessories. 
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For acute fluid collections 
1.Drainage is indicated if symptomatic or Infected 
2.Transpapillary drainage  via placement of  bridging 
stent  across ductal leak done 
( Varadarajulu et al-GI Endoscopy 2005;)       
 
ENDOSCOPIC DRAINAGE OPTIONS 
 
 TRANSMURAL DRAINAGE 
                 1 NON EUS GUIDED 
                 2 EUS GUIDED 
   TRANSPAPILLARY  DRAINAGE 
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ADVANTAGES OF EUS GUIDED DRAINAGE 
1 Color Doppler USG helps avoid vessels 
2 Cyst can be drained in absence of luminal   compression 
3    Allows characterization of   nature,number,size of fluid 
 collections  
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TRANSMURAL DRAINAGE
Varadarajulu et al
EUS   vs EGD FOR 
TRANSMURAL DRAINAGE
OF  PANCREATIC  
PSEUDO
CYSTS
( GI Endoscopy-
2008:68:1102)
EUS
GUIDED 
NON EUS 
GUIDED
TECHNICAL
SUCCESS-100%
TECHNICAL
SUCCESS-33%
CLINICAL
SUCCESS-100%
CLINICAL
SUCCESS-87%
 
TransPapillary Approach 
Preferred when  the pseudocyst communicates with  PD 
Complication rates are found to be lower(16%) compared to 
transmural(39%) 
( De palma et al-Hepatogastroenterology-2002) 
Stents may be placed into pseudocyst to effect drainage 
(Binmoeller KF Gastrointest Endosc 1995;)  
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Surgical Approaches 
There are various surgical methods available for the drainage of pancreatic 
pseudocyst. 
These include 
Cystogastrostomy 
        Cystoduodenostomy 
 Roux-en-Y cystojejunostomy 
 Distal pancreatectomy ± splenectomy 
 External drainage 
Cystogastrostomy: 
This is the most commonly employed mode of internal drainage for 
pseudocyst of the pancreas. This is ideal for most of the mature 
psedocysts which impinge and create an impression on the posterior 
gastric wall. 
This procedure is associated with minimum complications and chance of 
recurrence. Anterior gastrotomy is made ,  needle aspiration is done to 
confirm the location of pseudocyst. Now after taking stay sutures, the 
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posterior wall of stomach is opened immediately over the pseudocyst, 
pseudocyst is drained. Then, continuous sutures are placed anastomosing 
the pseudocyst to posterior gastric wall. 
The rare complications may involve abscess formation in the pseudocyst 
cavity. But generally the cavity collapses as the peristalsis    removes the 
cyst contents by reducing the pressure within. 
 
 
59 
 
 
 
 
Roux-en-Y cystojejunostomy 
This type of procedure is best suited for those cysts which don't have a 
gastric impression, but mature enough to warrant a drainage procedure. 
Jejunum is disconnected and Roux loop is taken up anastomosed with the 
pseudocyst in two layers. 
It may be combined with a lateral pancreatico-jejunostomy particularly in 
those with a dilated pancreatic system secondary to stricture of main 
pancreatic duct or obstruction. 
 
60 
 
 
 
 
Cystoduodenostomy 
This is a relatively rarer procedure which is  reserved for cases with 
pseudocyst in the head of the pancreas impinging on the C-loop of the 
duodenum. 
Care must be taken to avoid damage to the ampulla and distal part of CBD 
and pancreatic ducts. 
 
Distal pancreatectomy ± splenectomy 
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 This type of surgery was done for the pseudocysts in the tail of the 
pancreas. But with other modalities of intervention & better drainage 
procedures this therapy has become obsolete. 
External drainage 
External drainage of a pseudocyst pancreas  has  limited role but finds  use 
in the critically-ill patient. 
A controlled external fistula is an acceptable goal in these circumstances. 
Other rarer indications for external drainage include the control of an 
immature ruptured pseudocyst and when there is  bleeding into the cavity 
of the pseudocyst where there has been underrunning of the bleeding 
point.  
A Endoscopic intervention by means of a transpapillary stents following 
such  a surgery usually results in faster resolution  of the  external fistula. 
The use of long-acting somatostatin analogue also aids in this cause. 
 
Laparoscopic Procedures: 
All the above mentioned procedures can be laparoscopically, it has the 
advantage of faster recovery and return to normalcy. Care must be taken 
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while dealing with large cysts not to advertently rupture the cyst while 
introducing the ports. 
The post operative pain is generally much lesser than compared to open 
methods. 
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PROFORMA 
PRE OP : - 
Name :  Age :  Sex :  IP No. : 
Duration of symptoms : 
Co-morbid illness : 
DM : yes / no    IHD / CAD : yes / no 
HT : yes / no    TB : yes / no 
On admission : 
Pulse :    BP : 
Anemia : yes / no   Icterus : yes / no  
Pedal edema : yes / no   
CVS:     RS: 
P/A: 
Investigations : 
Hemogram: 
Renogram: 
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Liver Function Test: 
S.Amylase  S.Lipase  S.LDH  S.CALCIUM 
USG ABD: 
CECT ABD: 
MRCP:: 
ERCP:: 
OGD SCOPY: 
INTERVENTION DONE: - 
SURGICAL:: YES/NO; 
 IF YES DETAILS: 
USG GUIDED INTERVENTIONS: YES/NO: 
 IF YES DETAILS: 
ENDOSCOPIC INTERVENTIONS:: YES/NO 
 IF YES DETAILS: 
POST OP : - 
USG ABD TO NOTE FOR RESIDUAL PSEUDOCYST 
LFT AND S.AMYLASE/LIPASE 
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MATERIALS & METHODS 
The study is a Prospective Observational study conducted at Rajiv Gandhi 
Government General Hospital from July 2012 to December 2012. 
50  adult patients with symptomatic pancreatic pseudocyst were included in 
the study .   
Pseudocysts with greater than or equal to 6 weeks duration or cyst wall of 
6mm thick or more will be involved in the study. 
Children and traumatic pseudocysts, and Pseudocysts<6 weeks duration 
and wall thickness of < 6 mm were excluded from the study. 
Patients were subjected to  baseline investigation`s (Biochemistry, 
Haemogram, and Chest Skiagram). This was then  followed up by specific 
investigations like serum amylase, serum lipase, serum LDH, serum 
Calcium, liver function test. 
 USG – Abdomen and CT – Abdomen were done to all  to identify the 
morphology , size,  extent, shape of the pseudocyst, the relation to the 
pancreas and its accessibility from Gastrointestinal tract.  
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MRCP & ERCP was done to identify the pancreatic duct morphology, 
communication to the pseudocyst cavity, abnormalities and variations in 
minor and major draining systems, & to detect biliary pathology. 
 Each patient was then classified according to the type of pseudocyst and 
the mode  of therapeutic intervention was decided . 
 
They were subjected to either  
1. USG guided drainage 
2. Endoscopic drainage 
3. Surgical drainage 
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OBSERVATIONS & RESULTS 
The results of various procedures were compared and contrasted 
based on immediate relief of symptoms and post interventional 
complications. 
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Table 1 : Presumed Causes of Pancreatic Pseudocyst 
 
causes No. Of cases Percentage  
Alcohol related 40 80% 
Biliary 7 14% 
Both alcohol & biliary 2 4% 
Idiopathic 1 2% 
Total 50 100% 
 
 
Causes 
Alcohol related
Biliary
Both alcohol & biliary
Idiopathic
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Table 2 : Indications for Intervention: 
Indication No. Of cases Percentage 
Persistent pain 30 60% 
Gastric outlet obstruction 7 14% 
Obstructive jaundice 4 8% 
Infected cyst 3 6% 
Rupture 1 2% 
Others 5 10% 
Total 50  100% 
 
 
Indications 
Persistent pain
Gastric outlet obstruction
Obstructive jaundice
Infected cyst
Rupture
Others
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Table 3: Types of Intervention 
Interventional Modality No. Of cases percentage 
USG Guided Drainage 7 14% 
 
Endoscopic 
-Transpapillary 
-Transgastric 
12 
9 
3 
24% 
18% 
6% 
Surgery 
-Cystogastrostomy 
-Cystojejunostomy 
31 
18 
13 
62% 
36% 
26% 
Total 50 100% 
 
Intervention modality 
USG guided Drainage
Endoscopic
Surgery
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Table 4: Complications in USG Guided Drainage: 
Complications No.  
Recurrence 2 
Pancreatic fistula 1 
Bowel perforation 0 
Bleeding 0 
Pleural effusion 1 
Total 4 out of total 7 pts 
 0 0.5 1 1.5 2 2.5
Recurrence
Pancreatic fistula
Bowel perforation
Bleeding
Pleural effusion
Complications of USG  guideded  Drainage 
No.
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Table 5 : Complications in Endoscopic Guided Drainage: 
complications No.  
recurrence 2 
Pancreatic fistula 0 
Bowel perforation 0 
bleeding 1 
cholangitis 1 
total 4 out of total 12 pts 
 0 0.5 1 1.5 2 2.5
recurrence
Pancreatic fistula
Bowel perforation
bleeding
cholangitis
Complications of Endoscopic Drianage  
No.
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Table 6: Complications in Surgery - Cystogastrostomy: 
complications No.  
recurrence 1 
Pancreatitis 1 
bleeding 2 
Pleural effusion 1 
total 5 out of total 18 pts 
 
 
0 0.5 1 1.5 2 2.5
recurrence
Pancreatitis
bleeding
Pleural effusion
Complications of  Cystogastrostomy  
No.
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Table 7: Complications in Surgery - Cystojejunostomy: 
Complications No.  
Recurrence 1 
Pancreatitis 1 
Bleeding 1 
Pleural effusion 1 
Total 4 out of total 13 
 
 
 
Complications of Cystojejunostomy  
Recurrence
Pancreatitis
Bleeding
Pleural effusion
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Table 8: Comparison of USG VS Surgical Intervention: 
Treatment 
Modality 
No. Of 
complications 
No. Of Patients percentage 
USG Guided 
Drainage 
4 7 57.1 
Surgical 
Intervention 
9 31 29 
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Table 9: Comparison of Endoscopic Vs Surgical intervention 
Treatment 
Modality 
No. Of 
complications 
No. Of Patients percentage 
Endoscopic 
Drainage 
4 12 33.3 
Surgical 
Intervention 
9 31 29 
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Table 10: Comparison of Cysto-gastrostomy  VS Cysto-
jejunostomy 
Treatment 
Modality 
No. Of 
complications 
No. Of Patients percentage 
Cysto-
gastrostomy 
5 18 27.8 
Cysto-
jejunostomy 
4 13 30.8 
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RESULTS 
A total of 50 patients were included in the study. All the patients 
were available till the end of the study and for follow up. 
Out of 50 patients the cause of pancreatic pseudocyst was found 
to be alcohol consumption in 80% & biliary causes in  14%. 
The most common indication for intervention was persistent pain 
(60%) and Gastric outlet obstruction (14%). 
The type of intervention was chosen based on the physical state 
of the patient as well as location and type of the pseudocyst. 
USG Guided drainage was done in 14%, Endoscopic drainage - 
Transpapillary 18% & Transgastric 6%  and Surgical drainage 
procedure -  cystogastrostomy- 36% & cystojejunostomy 26%. 
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The complication rates in different procedures were as follows- 
USG guided drainage   -  4 out of 7 patients(57.1%) 
Endoscopic drainage    -   4 out of 12 patients(33.3%) 
Surgical drainage          -   9 out 31 patients(29%) 
 
Among surgical modalities the complication rates of 
cystogastrostomy was 27.8% against cystojejunostomy - 30.8%. 
The most common complication was recurrence of the 
pseudocyst that was found in 6 out of 50 patients - 12%. 
Bleeding , fistula formation, sepsis , pancreatitis, bowel injury 
were among the other complications. 
Elective surgery was done after a mean time gap of 45 days after 
diagnosing the pseudocyst.  
One patient who had a recurrence after USG guided aspiration 
was again intervened with surgical approach. 
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Post operatively repeat imaging showed incomplete resolution or 
recurrence of the pseudocyst in 12% patients. 
 
 
DISSCUSSION 
Morbidity rates of surgical management of pseudocyst range 
from 29%- 57.1%. It depends on the physical status of the 
patient, the  mode of intervention used for that particular patient 
and the need for more than one modality of treatment  
Patients who failed with non-operative interventions should have 
a period of stabilization prior to definitive surgery. It is important 
to reverse sepsis and to improve nutritional status prior to 
intervention 
It is technically challenging to operate on patients who failed 
nonoperative measures. The priority is  to completely abolish the 
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prior cystic structure once it has been decompressed and the 
walls have fused. 
 
 
Recommendations for Management 
 Without evidence of complications, simple observation for 
a  minimum of  6 wks 
 Infected pseudocysts should be managed with 
percutaneous drainage until the patient is stabilized with 
proper resuscitation and antibiotics. 
 Severe nutritional deficits, at times an indication for 
percutaneous drainage, should be addressed 
Once the pseudocyst is established as persistent, observe truly 
asymptomatic patients with small cysts 
 Intervention in all pseudocysts of size> 6 cm & symptomatic 
patients 
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 Use knowledge of the ductal anatomy to guide choice of 
interventional modality 
 Types V, VI, and VII pancreatic ductal injuries are all to 
be managed surgically 
 Types I and II are always managed conservatively or 
nonsurgically  
 Pancreatic ductal injury Types III and IV could be 
managed either way. 
 Significant complications are most likely to occur if non 
surgical measures are to be used in patients who are most 
likely to sustain complications.  
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CONCLUSIONS 
Surgical and endoscopic interventions for pancreatic 
pseudocysts are equally effective and safe with a less 
important role for percutaneous drainage. 
Eventhough various minimally invasive procedures have 
come up for the treatment of pseudocysts, till date surgery 
remains the gold standard. Endoscopic drainage has nearly 
the same success and complication rates as against 
surgery. So endoscopic therapy should be considered for 
appropriate patients. Moreover even if the endoscopic 
intervention fails there is always the second choice of a 
surgical option left open.   
At the same time USG guided percutaneous intervention 
has to be reserved for  very sick and morbid patients as an 
emergency life saving procedure only, it is not to be used as 
a definitive procedure. 
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Among surgical methods both cystogastrostomy and 
cystojejunostomy are equally effective if individualized 
according to the patient factors.   
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Annexure I 
MASTER CHART 
S.N0 NAME AGE SEX IP.NO LOCATION SIZE OTHER 
SPECIFICATIONS 
INTERVENTION COMPLI
CATONS 
FOLLOW 
UP 
1 VENKATESA
N 
41 M 71725 BODY 6*7 
CM 
 C.G  RES 
2 VIJAYAKUMA
R 
28 M 67903 TAIL 8*6C
M 
 C.J B RES 
3 VENDA 37 F 72472 BODY 7*6C
M 
 C.G  RES 
4 GOUSH 
BASHA 
34 M 79067 BODY 6*7C
M 
 C.G  RES 
5 VIJAYAKUMA
R 
34 M 67703 BODY 6*8C
M 
 TRANSPAPILL
ARY 
DRAINAGE 
 RES 
6 SHANKAR 42 M 79024 BODY 6*7 
CM 
 C.G  RES 
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7 KAVERI 37 F 82503 TAIL 6*7.5 
CM 
 C.J P RES 
8 JAYAKUMAR 70 M 79367 BODY 7*6C
M 
ARF USG GUIDED 
DRAINAGE 
PE RES 
9 MUNUSAMY 35 M 78727 BODY 7*7C
MM 
 T.G 
ENDOSCOPIC 
DRAINAGE 
 RES 
10 KUMAR 37 M 78456 BODY LARGE
ST 
7*8C 
MULTIPLE C.G  RES 
11 MANIKANDA
N 
30 M 79516 BODY 6*7C
M 
 C.G PE RES 
12 KUPPAN 45 M 80453 TAIL 7*6C
M 
 C.J  RES 
13 KUMAR 37 M 80876 BODY 7*7C
M 
 C.G  RES 
14 SURESH 27 M 79675 HEAD 7*6C
M 
PROXIMITY TO 
P.D 
T.P C RES 
15 UMAPATHY 35 M 80342 BODY 7*6C
M 
COMMUNICATI
NG WITH P.D 
T.P  RES 
16 VADIVU 55 F 79841 BODY 8*7C
M 
SEPSIS USG GUIDED 
DRAINAGE 
F RES 
17 THOPLAN 75 M 82825 BODY 7*7C
M 
INFECTED USG GUIDED 
DRAINAGE 
 RES 
18 NATARAJAN 55 M 82462 TAIL 6*7C
M 
 C.J  RES 
19 SEKAR 35 M 82224 BODY 7*7C
M 
 C.G  RES 
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20 MUTHURAJ 50 M 82343 BODY LARGE
ST7*7
CM 
MULTIPLE C.G  RES 
21 MUNIYAN 35 M 83010 TAIL 7*6 
CM 
 C.J  RES 
22 SELVI 27 F 84972 BODY 7*6 
CM 
PROXIMITY TO 
P.D 
T.P  RES 
23 GANAPATHI 25 M 82131 HEAD 7*7C
M 
COMMMUNICA
TING WITH THE 
PD 
T.P R N.RES 
24 SELVARAJ 45 M 83161 BODY 10*7C
M 
 C.G  RES 
25 MARIMUTH
U 
40 M 84012 TAIL 9*6C
M 
 C.J PE RES 
26 ARUL 30 M 84230 BODY 10*8C
M 
 T.G B RES 
27 KALIDAS 28 M 86213 BODY 9*6C
M 
COMMUNICATI
NG WITH P.D 
T.P  RES 
28 ANBAZHAGH
AN 
60 M 87215 BODY 10*6C
M 
INFECTED  U.S.G GUIDED 
DRAINAGE 
R N.RES 
29 RAJENDRAN 50 M 89310 TAIL 11*8 
CM 
 C.J  RES 
30 SUNDAR 43 M 90133 BODY 10*8C
M 
 C.G B RES 
31 RAVI 30 M 90833 TAIL 10*7C
M 
 C.J  RES 
32 KALYANI 60 F 91332 BODY 9*6C
M 
ARF U.S.G GUIDED 
DRAINAGE 
R N.RES 
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33  SUBBHAMM
A 
50 F 92000 TAIL 15*6 
CM 
 C.J  RES 
34 MAHENDRA
N 
27 M 92312 BODY 10*6 
CM 
COMMUNICATI
NG WITH P.D 
T.P R N.RES 
35 SHANTHI 55 F 93012 BODY 15*8C
M 
INFECTED U.S.G GUIDED 
DRAINAGE 
 RES 
36 KUMAR 40 M 93120 TAIL 10*8 
CM 
 C.J  RES 
37 MANOHAR 36 M 93222 HEAD 8*6C
M 
COMMUNICATI
NG WITH THE 
P.D 
T.P  RES 
38 ELUMALAI 30 M 93067 BODY 8*6 
CM 
 C.G  RES 
39 LAKSHMANA
NSWAMY 
40 M 93106 TAIL 15*10 
CM 
 C.J R N.RES 
40 ANBU 40 M 93086 BODY LARGE
ST 
MEAS
URIN
G 9*8 
CM 
MULTIPLE C.G R N.RES 
41 SUNDARRAJ 32 M 94321 TAIL 10*8 
CM 
 C.J  RES 
42 THANGARAJ 50 M 93400 BODY 10*9 
CM 
 C.G B RES 
43 KALIANNAN 60 M 93026 BODY 15*8 
CM 
INFECTED U.S.G GUIDED 
DRAINAGE 
 RES 
44 KRISHNAN 31 M 93122 BODY 9*6 
CM 
PROXIMTY TO 
P.D 
T.P  RES 
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45 NARESH 28 M 93202 BODY 8*6 
CM 
 T.G  RES 
46 VENGANNA 40 M 93426 TAIL 10*6 
CM 
 C.J  RES 
47 CHINNAH 60 M 93521 BODY 16*12 
CM 
 C,G P RES 
48 UMESH 31 M 93622 BODY 7*8 
CM 
 C.G  RES 
49 NATARAJ 38 M 93722 BODY 9*6 
CM 
 C.G  RES 
50 SRINIVASAN 40 M 94026 BODY 8*7 
CM 
 C.G  RES 
KEYS TO THE MASTER CHART: 
R-Recurrence, F-Pancreatic Fistula, PE-Pleural Effusion, B- 
Bleeding, C-Cholangitis, P-Pancreatitis. 
C.J-- Cysto-Jejunostomy, C.G.- Cysto-gastrostomy 
T.P- Transpapillary Endoscopic Drainage 
T.G- Transgastric Endoscopic Drainage 
